Evidence map›Paper›PMID 33081404›Full record

ArticleCancers2020

Cx43 Present at the Leading Edge Membrane Governs Promigratory Effects of Osteoblast-Conditioned Medium on Human Prostate Cancer Cells in the Context of Bone Metastasis.

Jonathan Boucher, Annie-Claire Balandre, Marjolaine Debant, Justine Vix, Thomas Harnois, Nicolas Bourmeyster, Elodie Péraudeau, Amandine Chépied, Jonathan Clarhaut, Françoise Debiais and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Extracellular Vesicles in Tumors: A Potential Mediator of Bone Metastasis.Frontiers in cell and developmental biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Jonathan BoucherCNRS ERL7003, Laboratory Signalisation et Transports Ioniques Membranaires (STIM), University of Poitiers, 1 Rue Georges Bonnet, TSA 51106, CEDEX 09, 86073 Poitiers, France.
Annie-Claire BalandreCNRS ERL7003, Laboratory Signalisation et Transports Ioniques Membranaires (STIM), University of Poitiers, 1 Rue Georges Bonnet, TSA 51106, CEDEX 09, 86073 Poitiers, France.
Marjolaine DebantCNRS ERL7003, Laboratory Signalisation et Transports Ioniques Membranaires (STIM), University of Poitiers, 1 Rue Georges Bonnet, TSA 51106, CEDEX 09, 86073 Poitiers, France.
Justine VixCNRS ERL7003, Laboratory Signalisation et Transports Ioniques Membranaires (STIM), University of Poitiers, 1 Rue Georges Bonnet, TSA 51106, CEDEX 09, 86073 Poitiers, France.
Thomas HarnoisCNRS ERL7003, Laboratory Signalisation et Transports Ioniques Membranaires (STIM), University of Poitiers, 1 Rue Georges Bonnet, TSA 51106, CEDEX 09, 86073 Poitiers, France.
Nicolas BourmeysterCNRS ERL7003, Laboratory Signalisation et Transports Ioniques Membranaires (STIM), University of Poitiers, 1 Rue Georges Bonnet, TSA 51106, CEDEX 09, 86073 Poitiers, France.
Elodie PéraudeauUniversity Hospital Center of Poitiers, 2 rue de la Milétrie, 86021 Poitiers, France.
Amandine ChépiedLaboratory of Experimental and Clinical Neurosciences, LNEC-INSERM U1084, UBM-Laboratoire de Cancérologie Biologique, CHU de poitiers, 2 Rue de la Milétrie, 86000 Poitiers, France.
Jonathan ClarhautUniversity Hospital Center of Poitiers, 2 rue de la Milétrie, 86021 Poitiers, France.
Françoise DebiaisCNRS ERL7003, Laboratory Signalisation et Transports Ioniques Membranaires (STIM), University of Poitiers, 1 Rue Georges Bonnet, TSA 51106, CEDEX 09, 86073 Poitiers, France.
Arnaud MonvoisinCNRS ERL7003, Laboratory Signalisation et Transports Ioniques Membranaires (STIM), University of Poitiers, 1 Rue Georges Bonnet, TSA 51106, CEDEX 09, 86073 Poitiers, France.
Laurent CronierCNRS ERL7003, Laboratory Signalisation et Transports Ioniques Membranaires (STIM), University of Poitiers, 1 Rue Georges Bonnet, TSA 51106, CEDEX 09, 86073 Poitiers, France.
Centre National de la Recherche Scientifique · FRInserm · FR

Funding

French Society of Rheumatology (SFR) Subvention 2016 N°3621Ligue Nationale contre le Cancer (comités 16 and 17) Subventions 2016-2019
6 · The paper itself

Abstract

Among the different interacting molecules implicated in bone metastases, connexin43 (Cx43) may increase sensitivity of prostate cancer (PCa) cells to bone microenvironment, as suggested by our in silico and human tissue samples analyses that revealed increased level of Cx43 expression with PCa progression and a Cx43 specific expression in bone secondary sites. The goal of the present study was to understand how Cx43 influences PCa cells sensitivity and aggressiveness to bone microenvironment. By means of Cx43-overexpressing PCa cell lines, we revealed a Cx43-dependent promigratory effect of osteoblastic conditioned media (ObCM). This effect on directional migration relied on the presence of Cx43 at the plasma membrane and not on gap junctional intercellular communication and hemichannel functions. ObCM stimulation induced Rac1 activation and Cx43 interaction with cortactin in protrusions of migrating PCa cells. Finally, by transfecting two different truncated forms of Cx43 in LNCaP cells, we determined that the carboxy terminal (CT) part of Cx43 is crucial for the responsiveness of PCa cells to ObCM. Our study demonstrates that Cx43 level and its membrane localization modulate the phenotypic response of PCa cells to osteoblastic microenvironment and that its CT domain plays a pivotal role.

Indexed as

bone metastasiscarboxy terminal domainconditioned mediumCx43gap junctionsmigrationprostate cancer

Identifiers

PMID33081404
PMCPMC7602984
OpenAlexW3092810291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.